NewsYour Health Matters


Remdesivir may not help patients with mild cases of COVID-19, new study says

Posted at 1:22 PM, Aug 22, 2020
and last updated 2020-08-22 13:22:37-04

A new study suggests that Remdesivir may not help patients who have moderate cases of COVID-19.

A total of 584 patients with moderate COVID-19 received either a 5 or 10-day course of Remdesivir or standard care.

Those on the 10-day course of Remdesivir did not have a significant improvement in outcomes compared to those who did not receive the drug.

The death rate was also similar.

However, those on the 5-day course did improve compared to those who received standard care.

But the researchers say the difference was "of uncertain clinical importance."